Promising results for Crofelemer as a treatment for cancer therapy-related diarrhea in breast cancer.

The article highlights promising results for Crofelemer, a potential treatment for diarrhea caused by cancer therapy in breast cancer patients. These findings, accepted for presentation at the San Antonio Breast Cancer Symposium (SABCS), suggest improved management of this challenging side effect. The full research details will be shared at the conference, offering further insights into Crofelemer's effectiveness as a treatment option.

November 04, 2024
6 Articles

Further Reading